Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

BACKGROUND: Identification of novel biomarker is important for development of molecular-targeted therapy agents for patients with hepatocellular carcinoma (HCC). This study aims to identify potential prognostic biomarkers and investigate epigenetic mechanism of HCC development. METHODS: Public bulk-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zengwei, Yang, Yuan, Chen, Wen, Li, Enliang, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800332/
https://www.ncbi.nlm.nih.gov/pubmed/35093119
http://dx.doi.org/10.1186/s12967-022-03249-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800332/
https://www.ncbi.nlm.nih.gov/pubmed/35093119
http://dx.doi.org/10.1186/s12967-022-03249-2

Ejemplares similares